Gene · 83990
Papers4,271
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,271
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Druggable Molecular Networks in BRCA1/BRCA2-Mutated Breast Cancer. | Biology (Basel) | 2025 | 40136510 | PubTator, text mining | PubMed |
| Pathogenic germline variants in cancer predisposition genes in patients with multiple primary cancers in an Asian population and the role of extended panel genetic testing. | ESMO Open | 2025 | 40068381 | PubTator, text mining | PubMed |
| Machine learning identifies clinical tumor mutation landscape pathways of resistance to checkpoint inhibitor therapy in NSCLC. | J Immunother Cancer | 2025 | 40032600 | PubTator, text mining | PubMed |
| Three- and four-stranded nucleic acid structures and their ligands. | RSC Chem Biol | 2025 | 40007865 | PubTator, text mining | PubMed |
| Multiplexed epigenetic memory editing using CRISPRoff sensitizes glioblastoma to chemotherapy. | Neuro Oncol | 2025 | 39998382 | PubTator, text mining | PubMed |
| Considerations for hereditary breast and ovarian cancer syndrome molecular diagnosis: experience from the clinical practice. | Breast Cancer Res Treat | 2025 | 39992612 | PubTator, text mining | PubMed |
| Genome sequencing enhances the diagnostic yield and expands the genetic landscape of male breast cancer. | Genet Med Open | 2025 | 39981113 | PubTator, text mining | PubMed |
| Mutations in homologous recombination repair genes in patients with metastatic endometrial cancer: association with clinical characteristics and prognosis. | J Gynecol Oncol | 2025 | 39950607 | PubTator, text mining | PubMed |
| Comprehensive bioinformatics analysis of selected germline variants of uncertain significance identified in a cohort of Sri Lankan hereditary breast cancer patients. | Hum Genomics | 2025 | 39940038 | PubTator, text mining | PubMed |
| Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer. | Eur J Hum Genet | 2025 | 39939714 | PubTator, text mining | PubMed |
| Effects of hydrazone-based G-quadruplex ligands on FANCJ/BRIP1-depleted cancer cells and a Caenorhabditis elegans dog-1-/- strain. | NAR Cancer | 2025 | 39927196 | PubTator, text mining | PubMed |
| Morphologic Correlations With Homologous Recombination Deficiency in High-grade Serous Carcinomas. | Int J Gynecol Pathol | 2025 | 39868725 | PubTator, text mining | PubMed |
| Germline predisposition in multiple myeloma. | iScience | 2025 | 39845416 | PubTator, text mining | PubMed |
| Primary mucinous cystadenocarcinoma of the breast: A case report and literature review. | Oncol Lett | 2025 | 39611063 | PubTator, text mining | PubMed |
| Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database. | J Gastroenterol | 2025 | 39570378 | PubTator, text mining | PubMed |
| Multi-ethnic heterozygote frequencies of cancer susceptibility genes to inform counseling of reproductive risk. | Genet Med | 2025 | 39570271 | PubTator, text mining | PubMed |
| Germline variants of homology-directed repair or mismatch repair genes in cervical cancer. | Int J Cancer | 2025 | 39440754 | PubTator, text mining | PubMed |
| Comparative sequencing study of mismatch repair and homology-directed repair genes in endometrial cancer and breast cancer patients from Kazakhstan. | Int J Cancer | 2025 | 39400928 | PubTator, text mining | PubMed |
| Germline Variants in Patients Affected by Both Uveal and Cutaneous Melanoma. | Pigment Cell Melanoma Res | 2025 | 39315505 | PubTator, text mining | PubMed |
| The pathologic and clinical outcomes of risk-reducing salpingo-oophorectomy in asymptomatic carriers of homologous recombination repair gene mutation. | J Gynecol Oncol | 2025 | 39028150 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/83990/papers?page=9